Ryan Deschner

Stock Analyst at Raymond James

(4.03)
# 229
Out of 5,443 analysts
20
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
10 Stocks
Name Action PT Current % Upside Ratings Updated
LQDA Liquidia
Maintains: Strong Buy
33 41
21.23 93.12% 4 Aug 13, 2025
TRVI Trevi Therapeutics
Maintains: Strong Buy
29 27
7.33 268.35% 3 Aug 8, 2025
PVLA Palvella Therapeutic...
Initiates Coverage On: Outperform
54
41.54 30% 1 Aug 6, 2025
ARDX Ardelyx
Maintains: Outperform
11 12
5.4 122.22% 2 Aug 5, 2025
APLS Apellis Pharmaceutic...
Maintains: Outperform
52 50
23.87 109.47% 2 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 122
38.19 219.46% 1 Jul 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
62
23.71 161.49% 1 Jul 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
15 4
4 0% 2 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
26 28
16.38 70.94% 3 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
12
n/a n/a 1 Jun 18, 2024